Expert Opinion on Pharmacotherapy, Volume 18, Issue 14 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 18, Issue 14 (2017)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Volume 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?
Joseph F. Goldberg & A. John Rush
Pages: 1417-1420
Published online: 11 Aug 2017
First Page PreviewforAddressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research? | Full Text | References | PDF (384.6 KB)
  • 2041 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Meta-analysis

Medical expulsive therapy in urolithiasis: a mixed treatment comparison network meta-analysis of randomized controlled clinical trials
Kannan Sridharan & Gowri Sivaramakrishnan
Pages: 1421-1431
Published online: 04 Aug 2017
AbstractforMedical expulsive therapy in urolithiasis: a mixed treatment comparison network meta-analysis of randomized controlled clinical trials | Full Text | References | PDF (1.5 MB) | Supplemental
  • 322 Views
  • 14 CrossRef citations
  • 0Altmetric

Treatment Evaluation

Article
Ipragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes
Akio Ohta, Hiroyuki Kato, Satoshi Ishii, Yosuke Sasaki, Yuta Nakamura, Tomoko Nakagawa, Yoshio Nagai & Yasushi Tanaka
Pages: 1433-1438
Published online: 11 Aug 2017
AbstractforIpragliflozin, a sodium glucose co-transporter 2 inhibitor, reduces intrahepatic lipid content and abdominal visceral fat volume in patients with type 2 diabetes | Full Text | References | PDF (675.7 KB)
  • 880 Views
  • 45 CrossRef citations
  • 0Altmetric

Key Paper Evaluation

Article
No cardiovascular benefit with evacetrapib – is this the end of the road for the ‘cetrapibs’?
Sheila A Doggrell
Pages: 1439-1442
Published online: 14 Aug 2017
AbstractforNo cardiovascular benefit with evacetrapib – is this the end of the road for the ‘cetrapibs’? | Full Text | References | PDF (330.6 KB)
  • 174 Views
  • 5 CrossRef citations
  • 0Altmetric

Review

Review
Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies
Federica Tomao, Claudia Marchetti, Alessia Romito, Anna Di Pinto, Violante Di Donato, Oriana Capri, Innocenza Palaia, Marco Monti, Ludovico Muzii & Pierluigi Benedetti Panici
Pages: 1443-1455
Published online: 18 Aug 2017
AbstractforOvercoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies | Full Text | References | PDF (1.1 MB)
  • 466 Views
  • 23 CrossRef citations
  • 0Altmetric
Review
Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson’s disease
Thomas Müller
Pages: 1457-1465
Published online: 08 Sep 2017
AbstractforCurrent and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson’s disease | Full Text | References | PDF (714.3 KB)
  • 213 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma
Jean-Luc Raoul, Marine Gilabert, Xavier Adhoute & Julien Edeline
Pages: 1467-1476
Published online: 14 Sep 2017
AbstractforAn in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma | Full Text | References | PDF (780 KB)
  • 683 Views
  • 20 CrossRef citations
  • 0Altmetric
Review
Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies
Michael J. Flynn & James M.G. Larkin
Pages: 1477-1490
Published online: 28 Aug 2017
AbstractforNovel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies | Full Text | References | PDF (1.3 MB)
  • 585 Views
  • 21 CrossRef citations
  • 0Altmetric
Review
Medical management for neurosurgical related seizures
Michela Ambrosi, Alessandro Orsini, Alberto Verrotti & Pasquale Striano
Pages: 1491-1498
Published online: 01 Sep 2017
AbstractforMedical management for neurosurgical related seizures | Full Text | References | PDF (738.7 KB)
  • 289 Views
  • 11 CrossRef citations
  • 0Altmetric
Review
Next generation beta adrenoreceptor agonists for the treatment of asthma
Ernesto Crisafulli, Annalisa Frizzelli, Alberto Fantin, Alessandra Manco, Angelo Mangia, Giovanna Pisi, Valentina Fainardi, Veronica Alfieri, Marina Aiello, Giuseppina Bertorelli & Alfredo Chetta
Pages: 1499-1505
Published online: 14 Sep 2017
AbstractforNext generation beta adrenoreceptor agonists for the treatment of asthma | Full Text | References | PDF (648.6 KB)
  • 349 Views
  • 4 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Fluocinolone acetonide for the treatment of diabetic macular edema
Daniele Veritti, Valentina Sarao, Laura Diplotti, Francesco Samassa & Paolo Lanzetta
Pages: 1507-1516
Published online: 09 Aug 2017
AbstractforFluocinolone acetonide for the treatment of diabetic macular edema | Full Text | References | PDF (771 KB)
  • 235 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Lifitegrast for the treatment of dry eye disease in adults
Eric D. Donnenfeld, Henry D. Perry, Alanna S. Nattis & Eric D. Rosenberg
Pages: 1517-1524
Published online: 04 Sep 2017
AbstractforLifitegrast for the treatment of dry eye disease in adults | Full Text | References | PDF (944.8 KB)
  • 6352 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Article
A review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate
Roy Fleischmann
Pages: 1525-1533
Published online: 24 Aug 2017
AbstractforA review of tofacitinib efficacy in rheumatoid arthritis patients who have had an inadequate response or intolerance to methotrexate | Full Text | References | PDF (921 KB)
  • 1202 Views
  • 18 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma
Daniel J. Lewis, Ellen J. Kim & Madeleine Duvic
Pages: 1535-1536
Published online: 18 Aug 2017
CitationforRecent advances in systemic targeted therapy for cutaneous T-cell lymphoma | Full Text | References | PDF (246.2 KB)
  • 809 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Letter
Reply to ‘Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma’
Teresa Amaral & Claus Garbe
Page: 1537
Published online: 18 Aug 2017
CitationforReply to ‘Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma’ | Full Text | References | PDF (181.7 KB)
  • 419 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Rizwana Parveen et al.
Review Article | Published online: 28 May 2024
Promising immunomodulators for management of substance and alcohol use disorders
Amanda M. Acuña et al.
Review Article | Published online: 28 May 2024
Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals
Krystyna Dobrowolska et al.
Review Article | Published online: 27 May 2024
Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants
Ann Childress
Review Article | Published online: 27 May 2024
View all latest articles